@tillymack
I don't believe recruitment has started yet. You could periodically check ClinicalTrials.gov later this year once they post the inclusion/exclusion criteria. For now, their Phase 2 criteria give a general idea,mthough Phase2 was conducted only in Israel since this is an Israel based company. Phase 3 is larger and will likely be multinational.

Unrelated, but if you or anyone is interested in anabolic therapy sooner, MGH (Mass General) in Boston is actively recruiting for a Phase 4 trial combining teriparatide (Forteo) and romosozumab (Evenity).